Patent ID: 6627204
Filing Date: 2003-09-30
Classification: A61K,A61P,C07K,G01N

Abstract:
An isolated polypeptide comprising a member selected from the group consisting of(a) an amino acid sequence as set forth in SEQ ID NO:2 or SEQ ID NO:4; (b) an immunogenic polypeptide comprising a fragment sequence of at least 15 amino acids that corresponds to an aligned contiguous segment of SEQ ID NO:2 or SEQ ID NO:4; wherein the isolated polypeptide, when administered to a subject in a suitable composition which can include an adjuvant, or a suitable carrier coupled to the polypeptide, induces an antibody or T-cell immune response to a polypeptide having the sequence of SEQ ID NO:2 or SEQ ID NO:4.